Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
83.00    0.00 (0.00%)
Bid:
82.00
Ask:
84.00
Spread: 2.00 (2.439%)
Market Cap: £86.80m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

Trading Update

21 May 2026 07:00

RNS Number : 1624F
SDI Group PLC
21 May 2026
 

SDI Group plc

("SDI", the "Company", or the "Group")

 

Trading Update

 

21 May 2026 - SDI Group plc, the buy and build group, focused on companies which design and manufacture specialist lab equipment, industrial & scientific sensors and industrial & scientific products, provides a trading update for the year ended 30 April 2026 ("FY26").

 

The Company expects full year earnings to be in line with current market expectations1, with strong trading over the second half of the year, despite the broader macroeconomic challenges. The year saw an improvement in operating margin delivering in-line earnings, with revenue at the lower end of expectations. The Group generated stronger organic growth in FY26, particularly during the second half of the financial year.

 

At 30 April 2026, following the acquisition of PRP Optoelectronics, the Group had net debt of £24.0m (excluding deferred consideration of £0.7m) and £4.0m of undrawn bank facility (excluding a £9.0m accordion option).

 

The Group has a strong order book moving into FY27 and looks forward to providing shareholders with a comprehensive update at the full year results, which are expected to be announced in late July.

 

Operational Update

 

The Group strategy is to drive growth by acquiring and developing niche industrial and scientific businesses that address critical customer challenges, whilst supporting organic growth within the portfolio through strategic initiatives, maximising synergies, operational efficiencies and cross-sell opportunities where appropriate.

 

Organic

During the year, there has been solid order intake from all divisions, with highlights including:

· Sentek securing a significant contract with a multinational industrial manufacturing customer;

· Scientific Vacuum Systems receiving a multimillion-pound contract from one of the world's largest consumer brands;

· Chell building on last year's strong performance, with continued demand for its products from its diverse customer base including gas meter manufacturers, aerospace and Formula 1;

· LTE Scientific and Safelab Systems securing, and in the process of delivering, significant contracts for key customers;

· Severn Thermal Solutions continuing to execute existing significant contracts for nuclear fusion applications; and

· Fraser Anti-Static Techniques and InspecVision seeing sustained demand for their products from international customer bases, including South Korea and North America respectively.

 

Acquisitions

During the year, the Group completed two acquisitions, with both businesses performing well post-acquisition:

· Severn Thermal Solutions, a designer and manufacturer of high temperature furnace systems and environmental chambers for advanced material processing and testing, acquired in June 2025; and

· PRP Optoelectronics ("PRP"), a designer and manufacturer of custom high performance microLEDs, LED light engines and monolithic LEDs for a range of applications within the avionics, defence and industrial sectors, acquired in February 2026.

 

 

Stephen Brown, Chief Executive Officer of SDI, said:

 

"We are proud to have delivered a strong performance in FY26, against the backdrop of increasing macroeconomic and geopolitical uncertainty, further underpinning the value of our portfolio model. New product development, coupled with new client wins both internationally and in the UK, and partnering on pioneering projects remain the mainstay of our business.

Our strategy remains unchanged - to continue to support organic growth across the portfolio whilst exploring opportunities to expand the business through targeted acquisition."

 

 

[1] Analysts from SDI's joint corporate brokers Cavendish Capital Markets Limited and Stifel together with Progressive Equity Research regularly provide research on the Company, accessible from SDI's website, and the Group considers the average of their forecasts to represent market expectations, which at 20 May 2026, for FY26 were Sales of £75.4m and Adjusted Profit Before Tax of £9.8m.

 

 

Enquiries:

 

SDI Group plc

Stephen Brown, Chief Executive Officer

Amitabh Sharma, Chief Financial Officer

James Dimitriou, Group Head of Corporate Development

+44 (0)1223 727144

www.sdigroup.com

 

Cavendish Capital Markets Ltd (NOMAD & Joint Corporate Broker)

Ed Frisby / Seamus Fricker - Corporate Finance

Andrew Burdis / Sunila de Silva - Corporate Broking

 

+44 (0)20 7220 0500

Stifel (Joint Corporate Broker)

Fred Walsh / Brough Ransom / Ben Good

 

+44 (0) 20 7710 7600

Vigo Consulting (Financial Communications)

Tim McCall / Rozi Morris / Fiona Hetherington

 

+44 (0)20 7390 0230

SDIGroup@vigoconsulting.com 

 

About SDI Group plc

 

SDI Group plc is a group of small to medium size companies with specialist industrial and scientific products in growth sector niches which help solve customers' key challenges.

 

It specialises in the acquisition and development of companies that design and manufacture specialist products for use in lab equipment, industrial & scientific sensors and industrial & scientific products.

 

Its portfolio of businesses serves a broad spectrum of specialised markets, ranging from advanced industrial technologies (aerospace & defense, manufacturing, semiconductors and precision measurement) to scientific and medical applications (life sciences, healthcare, astronomy).

 

SDI aims to continue its growth through driving the organic growth of its portfolio companies and by the acquisition of complementary technology businesses with established reputations in global markets.

 

For more information, please see: www.SDIGroup.com

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGZKNGGGVZM
Date   Source Headline
12th Dec 20127:00 amRNSSynoptics Health: ProReveal product launch update
15th Nov 20124:59 pmRNSHolding(s) in Company
16th Oct 20127:00 amRNSIssue of Equity
11th Sep 20123:20 pmRNSResult of AGM
25th Jul 201212:01 pmRNSDirector/PDMR Shareholding
25th Jul 20128:12 amRNSFinal Results
29th May 201210:05 amRNSDirectorate Change
16th Dec 20117:00 amRNSHalf Yearly Report
15th Sep 20111:52 pmRNSAppointment of Acting Managing Director
1st Sep 20112:04 pmRNSResult of AGM
18th Jul 20115:01 pmRNSNotice of Results
1st Jun 20111:00 pmRNSTrading Update
17th Jan 20117:00 amRNSHalf Yearly Report
10th Dec 20103:48 pmRNSTrading Update
27th Sep 201012:01 pmRNSSector Change
23rd Sep 20103:15 pmRNSResult of AGM
19th Jul 20102:27 pmRNSDirector/PDMR Shareholding
19th Jul 20107:00 amRNSFinal Results
16th Jul 20108:58 amRNSAnalyst Presentation
7th Jul 201012:08 pmRNSNotice of Results
7th Jul 201012:01 pmRNSChange of Adviser
28th Jun 20107:00 amRNSSynbiosis Update
24th May 20107:00 amRNSDirectorate Change
21st May 20107:00 amRNSTrading Update
16th Mar 201012:25 pmRNSDirectorate Changes
2nd Mar 20109:59 amRNSTrading Update
10th Feb 20107:00 amRNSNew Atik Camera
25th Jan 20107:00 amRNSHalf Yearly Report
4th Jan 20104:20 pmRNSDirectorate Change
9th Dec 20091:46 pmRNS12 Months on AIM
21st Oct 200911:21 amRNSResult of AGM
16th Oct 20093:45 pmRNSIssue of Equity
14th Oct 20094:50 pmRNSChange of Adviser
14th Sep 20097:00 amRNSFinal Results
18th Jun 20094:52 pmRNSExercise of Options
7th Apr 20097:00 amRNSTrading Statement
6th Feb 20094:14 pmRNSDirector/PDMR Shareholding
27th Jan 20097:30 amRNSInterim Results
8th Dec 20087:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.